Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
112.29
-0.32 (-0.28%)
Streaming Delayed Price
Updated: 12:51 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval
March 26, 2024
Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.
Via
InvestorPlace
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
March 25, 2024
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.
Via
InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
March 22, 2024
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.
Via
The Motley Fool
3 Stocks to Buy Right Now for the Coming Recession
March 21, 2024
With numerous economic indicators souring, these three stocks to buy for a recession will protect your portfolio's downside.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
3 Resilient Stocks to Protect Your Wealth During a Recession
March 21, 2024
Discover three recession-resistant stocks with growth leads in the consumer staples, household products, and healthcare industries.
Via
InvestorPlace
What the Options Market Tells Us About Abbott Laboratories
March 19, 2024
Via
Benzinga
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
March 08, 2024
Via
Benzinga
Is Abbott Laboratories a Top Dividend Growth Stock to Buy Now?
March 07, 2024
Abbott Laboratories has been growing its dividend at a blistering pace. Is its stock a buy?
Via
The Motley Fool
What's Going On With Abbott Laboratories Stock On Friday?
March 15, 2024
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst
March 15, 2024
Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil.
Via
Investor's Business Daily
Topics
Death
Exposures
Death
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.
Via
InvestorPlace
Topics
ETFs
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
March 11, 2024
These are some of the best-performing stocks in what's arguably society's most important industry.
Via
The Motley Fool
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
March 06, 2024
FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant...
Via
Benzinga
Exposures
Product Safety
Exploring ABBOTT LABORATORIES (NYSE:ABT)s quality characteristics.
March 05, 2024
Why the quality investor may take a look at ABBOTT LABORATORIES (NYSE:ABT).
Via
Chartmill
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
March 01, 2024
Via
Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
February 26, 2024
Abbott's earnings have soared over the past decade.
Via
The Motley Fool
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
March 06, 2024
These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns.
Via
InvestorPlace
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
March 06, 2024
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.
Via
Investor's Business Daily
Exposures
Product Safety
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
March 03, 2024
There is a world of opportunities ahead for this healthcare giant.
Via
The Motley Fool
Nearing Retirement? These Stocks Are as Cautious as They Come
February 28, 2024
Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further.
Via
The Motley Fool
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
February 27, 2024
These stocks don't offer the highest yields, but their payouts are growing fast.
Via
The Motley Fool
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
February 23, 2024
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
February 20, 2024
Via
Benzinga
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via
Benzinga
Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar.
February 26, 2024
Discover 7 under-the-radar stock trends set to make waves in the stock market. Find out why savvy investors are tuning in.
Via
InvestorPlace
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.
Via
InvestorPlace
Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade
February 21, 2024
In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday.
Via
Investor's Business Daily
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
February 18, 2024
These stocks reward you during any market environment.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.